Cadrenal Therapeutics, Inc.
CVKD
$10.51
$1.6518.62%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 9.70M | 9.33M | 7.88M | 6.75M | 4.92M |
| Depreciation & Amortization | 6.70K | 6.70K | 6.80K | 1.90K | 2.10K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 14.67M | 14.40M | 13.13M | 10.96M | 7.95M |
| Operating Income | -14.67M | -14.40M | -13.13M | -10.96M | -7.95M |
| Income Before Tax | -14.39M | -14.11M | -12.83M | -10.65M | -7.61M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -14.39 | -14.11 | -12.83 | -10.65 | -7.61 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -14.39M | -14.11M | -12.83M | -10.65M | -7.61M |
| EBIT | -14.67M | -14.40M | -13.13M | -10.96M | -7.95M |
| EBITDA | -14.67M | -14.39M | -13.13M | -10.96M | -7.94M |
| EPS Basic | -7.82 | -8.69 | -9.06 | -8.54 | -7.05 |
| Normalized Basic EPS | -4.89 | -5.43 | -5.66 | -5.33 | -4.41 |
| EPS Diluted | -7.82 | -8.69 | -9.06 | -8.54 | -7.05 |
| Normalized Diluted EPS | -4.89 | -5.43 | -5.66 | -5.33 | -4.41 |
| Average Basic Shares Outstanding | 7.49M | 6.55M | 5.66M | 4.88M | 4.31M |
| Average Diluted Shares Outstanding | 7.49M | 6.55M | 5.66M | 4.88M | 4.31M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |